The art of forging neurons: direct reprogramming of somatic cells into induced neuronal cells
For millennia, the idea of transmogrifying one being into another has fascinated mankind. Homer told of the ability of the sorceress Circe to transform human beings into pigs using her powers of magic. Likewise, developmental neurobiologists attempt to alter the identity of a given cell in a targeted manner. Here, a certain cellular identity is based on a transcriptional regulatory network which is maintained through positive feedback loops and induces a particular gene expression profile. The resulting (meta-)stable state of gene expression is referred to as a cellular program. By manipulating this program, e.g., via over-expression of regulatory key components such as transcription factors or microRNAs, cells can be maneuvered into an unstable state, which permits the establishment of a new transcriptional regulatory network (. Fig. 1 ), and as a consequence allows the cell to acquire a new identity: a process which has won fame as cellular reprogramming. In this article we discuss current approaches and developments within the field of direct reprogramming of somatic cells into induced neuronal cells (iNs) and induced neural stem cells (iNSCs).
Rewinding the film: regaining pluripotency
Of all forms of reprogramming, our understanding of the cellular mechanisms underlying the reprogramming of somatic cells such as fibroblasts into induced pluripotent stem cells (iPSCs), i.e., cells with the same broad developmental potential as embryonic stem (ES) cells, albeit incomplete, is by far the most advanced. A prerequisite of the strategy, developed by Takahashi and Yamanaka, of reprogramming fibroblasts via the four transcription factors Oct4, Sox2, Klf4, and cMyc [9] was a relatively good knowledge of the transcriptional mechanisms underlying the maintenance of pluripotency in ES cells. Initially, key transcription factors are exogenously introduced into the cells of origin, eventually resulting in the stochastic induction of certain target genes. In the event of successful "booster detonation, " this stochastic phase is followed by the hierarchical reactivation of endogenous factors constituting the transcriptional core network that underlie pluripotency and ultimately lead to the complete reprogramming of the cell. Presumably, the initially stochastic activation of pluripotency genes depends on their epigenetic status (DNA methylation, histone modifications). Thus, during this initial phase, enzymes that help to erase existing epigenetic signatures and establish new ones play an important role.
To a new identity without digressions: direct reprogramming
In principle, it is conceivable that each cell type has its own transcriptional core network, including neural stem cells and their progeny, i.e., neurons, astroglia, and oligodendroglia. However, these core networks, provided they exist, are far less well understood compared to those of pluripotent stem cells. Nonetheless, researchers have succeeded in forcing a new, neural identity on somatic cells of different origin by ectopic expression of developmentally relevant transcription factors.
Historically, this feat was first achieved within the neuroectodermal lineage, namely from astroglia to iNs [3] , but has since also been successfully accomplished even beyond the germ layer barriers from cells of mesodermal and endodermal origin. In this instance of reprogramming, cells do not pass through a pluripotent stage and the acquisition of the new identity occurs directly, typically even without requiring cell division.
The tool box: transcription factors and microRNAs
In the first study demonstrating the successful transdifferentiation of non-neuronal cells into iNs, the transcription factor Pax6 was introduced via retroviral particles into astroglia of the cerebral cortex of young postnatal mice [3] . This experiment was based on the finding that Pax6 expression accounts for the neurogenic potential of radial glia during neurogenesis and that loss of Pax6 expression marks the end of neurogenesis and the beginning of gliogenesis. Indeed, Magdalena Götz and her team-then at the Max Planck Institute of Neurobiology, Martin-
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sried-were able to show that, under the influence of Pax6, astroglia adopt a neuronal morphology and marker expression while losing their astroglial properties [3] .
In 2010, the laboratory of Marius Wernig at Stanford University pulled off the feat of reprogramming cells of mesodermal origin, namely fibroblasts, into functional iNs via forced expression of three transcription factors [10] . To this end, they started off from a larger pool of candidate factors, and then eliminated one-by-one on empirical basis until finally identifying the most efficient mix (Ascl1, Brn2, Myt1l) of transcription factors. Intriguingly, the majority of the resulting iNs displayed features of glutamatergic neurons.
This study virtually triggered a hype: following the same principle, several laboratories succeeded in generating even dopaminergic neurons from fibroblasts. Here, the recipe of the transcription factor cocktail was based on those transcription factors that regulate the genesis of dopaminergic neurons during development of the midbrain. In analogy, varying the composition of the transcription factor cocktail permitted the generation of spinal motor neurons. These could be transplanted into the spinal cord of chick embryos where they were even found to project their axons to the skeletal musculature, where they established synaptic endplates [11] .
The next challenge was to translate this approach to fibroblasts of human origin. Once more, the laboratory of Wernig was the first to generate functional human iNs, which required enlargement of the arsenal of transcription factors in order to obtain similarly good results as when reprogramming mouse fibroblasts. Another strategy was picked up by the laboratory of Gerald Crabtree, likewise at Stanford University. His laboratory is interested in certain protein complexes, which govern the shuffling of nucleosomes and thereby influence the local compactness of chromatin. ES cells, neuronal progenitors, and postmitotic neurons differ in their composition of the so-called brahma-associated factor (BAF) chromatin remodeling complex and thus confer specificity to the regulation of gene expression. Interestingly, the subunit BAF53a of the progenitor-specific BAF complex becomes repressed during neuronal differentiation via the microRNAs miR-9/9* and miR124 and replaced by the neuron-specific subunit BAF53b. Crabtree took advantage of this mechanism to reprogram human fibroblasts into iNs [12] . Indeed, his team could show that expression of these microRNAs induces neuronal marker genes in human fibroblasts. While the yield was rather low, combining this approach with the expression of neurogenic transcription factors (NeuroD2, Ascl1, Myt1l) resulted in the successful conversion of adult human skin fibroblasts into electrophysiologically functional iNs.
MicroRNA124 does not only regulate the composition of the BAF chromatin remodeling complex, but is also involved in other gene regulatory circuits that are important for neuronal differentiation during development. For instance, the RNA binding protein poly-pyrimidine-tractbinding (PTB) represses neuronal gene expression via the regulation of microR-NA binding to its target RNAs. During embryogenesis, PTB becomes in turn repressed by miR124, ultimately leading to the induction of neurogenesis. If one aborts expression of PTB via short hairpin RNAs, it is possible to transdifferentiate fibroblasts into iNs with functional electrophysiological properties.
Fine-tuning the set crews: small molecule inhibitors to improve reprogramming efficiency
Regardless of the successes achieved so far in the direct reprogramming of somatic cells into iNs, the question remains as to whether the donor cell signature can be erased completely and replaced by that of iNs. In fact, the degree of differentiation of the starting cell population seems to play a crucial role as terminally differentiated postmitotic hepatocytes can be transdifferentiated into iNs, retaining however a traceable epigenetic signature of the original identity. Similarly, this holds true for adult fibroblasts, which are considerably harder to convert into functional iNs. For this reason, Oliver Brüstle and his team at the University of Bonn sought for ways of improving reprogramming efficiency and found that the combinatorial use of the GSK-3β (CHIR99021) and SMAD (SB-431542) inhibitors led to strikingly enhanced reprogramming efficiency and purity of the resultant iN population [5] . Intriguingly, inhibition of the transforming growth factor-β (TGF-β)/SMAD sig- nalling pathway augments the efficiency of reprogramming of fibroblasts into iNs and iPSCs, suggesting parallels in both reprogramming processes.
Direct reprogramming of somatic cells into induced neural stem cells
A general disadvantage of direct reprogramming of fibroblasts into iNs is that only one iN is generated per fibroblast. In order to circumvent this limitation, several research teams have attempted to convert fibroblasts into iNSCs [6] . This has the advantage that, in principle, neural stem cells can be infinitely expanded and differentiated not only into neurons, but also into glial cells, a phenomenon moving increasingly into the focus of clinical research. Intriguingly, the different teams came up with quite diverse strategies for generating iNSCs. The Wernig laboratory analyzed a battery of candidate transcription factors and found that the triad of Brn2, Sox2, and FoxG1 can induce tripotent neural progenitors, which can in turn differentiate into forebrain-like neurons, astrocytes, and oligodendrocytes. The latter were capable of integrating in vivo upon transplantation into the neonatal brain and of improving myelination in shiverer mice, which otherwise exhibit a defect in myelination.
The Schöler laboratory at the Max Planck Institute of Molecular Biomedicine, Münster, chose a different approach to the generation of iNSCs. The basic idea consisted of replacing the Oct4 gene of the Yamanaka cocktail by another POU domain containing transcription factor, namely Brn4. Interestingly, iNSCs derived in this way displayed a similar molecular signature to neural stem cells from the hindbrain and spinal cord, indicating that different reprogramming protocols lead to distinct regionalization of the resultant iNSCs.
Yet another approach to generating iNSCs from fibroblasts was pursued by Frank Edenhofer's laboratory at the University Bonn. They started from the assumption that during the initial phase of reprogramming towards pluripotency, partially reprogrammed cells pass through an unstable stage in which cells with neural stem cell properties could emerge spontaneously. Indeed, they were able to show that by curtailing reprogramming via temporally limited delivery of Oct4 (through transient protein transduction), fibroblasts are induced to generate iNSCs.
Direct reprogramming of cells endogenous to the brain
The reprogramming of fibroblasts into iNs or iNSCs makes it possible to gain important insights into the barriers which impede transdifferentiation and into possible solutions to overcome these. It is also conceivable that iNs and iNSCs generated via direct reprogramming may be used to model human neurodegenerative diseases or even transplantation, and hence cell therapy. However, it is important to clarify whether clinically relevant types of neurons, for example dopaminergic neurons of the substantia nigra, can be obtained in this way, and whether these would be functionally equivalent or even superior to neurons differentiated from iPSCs. A particular advantage of direct reprogramming lies in the possibility of implementing this approach in situ within the relevant tissue. The most impressive example of such direct in vivo reprogramming was provided by the laboratory of Deepak Srivastava at the Gladstone Institute of Cardiovascular Disease, San Francisco. Cardiofibroblasts could be converted into functional cardiomyocytes via retroviral expression of the transcription factors Gata4, Mef2c, and Tbx5 directly within the damaged heart tissue [7] .
To extrapolate this approach to the central nervous system, suitable target cell populations that are amenable to reprogramming into neurons need to be identified. In principle, candidate cell population comprise: (i) the different types of macroglia, particularly astrocytes and oligodendrocyte precursor cells, (ii) microglia, and (iii) as our own studies have shown, microvessel-associated pericytes.
As mentioned above, the laboratory of Magdalena Götz pioneered the field by demonstrating that astroglia isolated from the cerebral cortex of young mice can be driven towards neurogenesis via forced expression of Pax6. Astroglia represents an interesting target cell population, as they exhibit many similarities to radial glia during development and stem cell astroglia within the adult neurogenic zones, and can de-differentiate upon injury. Depending on the severity of tissue insult, this reactivation of astroglia results in transient cell cycle re-entry, associated with an increased cellular plasticity. In fact, it has recently been shown that reactive astroglia can give rise to so called neurospheres upon culturing in vitro. This provides evidence that reactive astroglia can acquire stem cell-like properties.
In order to instruct the genesis of distinct neuron subtypes from astroglia, we examined the effect of forced expression of transcription factors crucially involved in the generation of glutamatergic and GABAergic neurons during forebrain de- velopment. Indeed, we were able to show that astroglia can be converted into glutamatergic iNs via retrovirus-mediated expression of neurogenin-2 (Neurog2) [2] . These neurons did not only exhibit glutamatergic synaptic transmission, but also morphological features of glutamatergic projection neurons such as synaptic spines (. Fig. 2) . In contrast, when astroglial cells were transduced with retroviruses encoding the transcription factors Dlx2 or Ascl1, they transdifferentiated into iNs with characteristics of GABAergic neurons [2] .
A particularly exciting finding was that the reprogrammed cells featured similar types of action potential discharge patterns to those observed in GABAergic neurons derived from the medial ganglionic eminence, falling into the categories of fast-spiking or low-threshold burstspiking interneurons (. Fig. 3 ). The next step will now be to evaluate whether such direct reprogramming of astroglial cells into distinct neuron subtypes can also be achieved in vivo.
A phenomenon akin to the reactivation of astroglia has been described for pericytes within the spinal cord. Christian Göritz and his colleagues at the Karolinska Institute in Stockholm provided evidence that a subpopulation of pericytes (type A pericytes) becomes activated upon spinal cord lesion and commences to proliferate. As a consequence, pericytes lose their contacts to the endothelium and migrate to the lesioned parenchyma, where they differentiate into extracellular matrix producing stromal cells and thus crucially contributing to scar formation and wound healing [1] . Whether such reactivation of pericytes and hence a regenerative role following injury can be elicited from pericytes within the adult brain has not yet been revealed. However, data from the spinal cord and other tissues suggest that pericytes indeed possess a remarkable degree of plasticity within the adult tissue. For instance, the group of Giulio Cossu at the Ospedale San Raffaele in Milan could show that pericytes isolated from the adult human skeletal muscle can adopt properties of muscle cell progenitors. When these pericytes were isolated and transplanted into chronically damaged muscle in mice, they were capable of fusing with myofibers and contributing to muscle regeneration in a mouse model of the Duchenne muscular dystrophy. Furthermore, the research team examined the behavior of endogenous pericytes within the skeletal muscle of adult mice and found that an intrinsic myogenic differentiation potential becomes further augmented by injury.
Our own studies indicate that pericytes reside within the adult human brain that could be used for direct reprogramming into iNs [4] . We were able to isolate and expand pericyte-derived cells from the cerebral cortex of adult patients. Following retrovirus-mediated expression of the transcription factors Sox2 and Ascl1, these pericyte-derived cells transdifferentiated into functional iNs (. Fig. 4 ). However, electrophysiologically, these cells featured properties of rather immature neurons, which may be accounted for by the generally very slow maturation of human neurons. Alternatively, the immature state may reflect only partial reprogramming. Interestingly, the analysis of iNs generated in this way revealed GABA immunoreactivity and parvalbumin expression, suggesting the acquisition of a GABAergic neuron phenotype.
The ultimate goal of such experiments is to reprogram cells endogenous to the central nervous system (CNS) into neurons or neural stem cells in situ, as this has been so successfully pioneered by the laboratory of Deepak Srivastava in the case of the heart. Paola Arlotta from Harvard University, USA, is a vanguard of direct in vivo reprogramming. Starting from their groundbreaking observation that the transcription factor Fezf2 is essential for the specification of cortical progenitors into corticofugal neurons, Arlotta and her coworker Caroline Rouaux undertook an attempt to reprogram ventral telencephalic progenitors, which normally differentiate into GABAergic projection neurons of the striatum, into corticofugal neurons by forced expression of Fezf2. Indeed, they succeeded in demonstrating that electroporation of Fezf2 into the embryonic striatum in utero results in the genesis of glu- tamatergic neurons that not only exhibited cortical pyramidal neuron morphology, but gave rise to subcortical axonal projections, some of which even reached the spinal cord. In a subsequent study, the two researchers wanted to know whether such reprogramming can still be induced after the neurons have become postmitotic [8] . Strikingly, postmitotic neurons within cortical layers 2/3 which normally form callosal projections could be reprogrammed into corticofugal neurons. However, this conversion was restricted to the early phases of their postmitotic life. This observation led these authors to propose the concept of a "time window of nuclear plasticity". Most likely, reprogramming is prevented at a later stage by "fixation" of the neuronal identity by epigenetic modifications. Arlotta and colleagues now aim to fathom ways of prolonging or even re-opening this window of nuclear plasticity.
In conclusion, it must be said that we are only at the beginning. For the first time, reprogramming permits us to scrutinize autologous (patient-specific) neurons to better understand the underlying disease mechanisms. This will undoubtedly lead to a considerable gain in knowledge and enable systematic testing of the effects of drugs on human nerve cells. Furthermore, there is legitimate hope that cellbased therapeutic approaches will receive new inputs via the evolvement of indirect and direct reprogramming strategies. In an ideal world, it might then be possible to not just replace individual nerve or glial cells via reprogramming, but to recreate entire germinative zones within the damaged CNS tissue. These may then be able to provide our brain with additional plasticity or even regenerative capacity, not unlike those zones of physiologically active adult neurogenesis, via the large scale output of new neurons. 
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